Cargando…
CAR-T-Zell-Therapie beim multiplen Myelom
Chimeric antigen receptor (CAR) T-cell treatment is a novel immunotherapy utilizing the patientʼs own immune system as a “weapon against tumor cells”. In patients with multiple myeloma (MM), CAR T-cell therapy has been investigated in clinical trials. The current data on B‑cell maturation antigen (B...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217003/ https://www.ncbi.nlm.nih.gov/pubmed/33942145 http://dx.doi.org/10.1007/s00108-021-01043-8 |